Investors

Shield Therapeutics is well positioned to become a fast growing, independent, international specialty pharmaceutical company.

Advisor Contacts

Nominated Advisor and Joint Broker

Peel Hunt LLP, 120 London Wall London EC2Y 5ET

Tel: +44 (0)20 7418 8900

Joint Broker

finnCap, 60 New Broad Street London EC2M 1JJ

Tel: +44 (0)20 7220 0500

Auditors

KPMG LLP, Quayside House, 110 Quayside Newcastle Upon Tyne NE1 3DX

Tel: +44 (0)19 1401 3700

Legal Advisors

Stephenson Harwood LLP, 1 Finsbury Circus, London EC2M 7SH

Tel: +44 (0)20 7329 4422

Tax Advisors

Ernst & Young LLP, Citygate St James’ Boulevard Newcastle upon Tyne NE1 4JD

Tel: +44 (0)19 1247 2500

Investor Relations and Financial PR

Walbrook PR Ltd, 4 Lombard Street London EC3V 9HD

Tel: +44 (0)20 7933 8780

Email: shield@walbrookpr.com

Registrar

Link Asset Services Limited, The Registry 34 Beckenham Road Beckenham Kent BR3 4TU

Tel: +44 (0)871 664 0300

Shield Therapeutics plc

Shield Therapeutics plc, Northern Design Centre Gateshead Quays, Gateshead NE8 3DF

Tel: +44 (0)191 511 8500

Email: investorrelations@shieldtx.com